Cointime

PeLeMed

company

About

PeLeMed is a drug development company working on the discovery of anti-cancer drugs.

  • 11 - 50

Highlights

Total Funding Amount
₩6.50B
Funding Rounds
1
Investors
2

Details

Last Funding Type
Series A
Last Funding Money Raised
₩6.50B
Industries
Biotechnology,Medical,Therapeutics
Founded date
Jan 1, 2020
Number Of Employee
11 - 50
Operating Status
Active

PeLeMed is a drug development company working on the discovery of anti-cancer drugs. The company's innovative therapeutic candidates through type 1 kinase inhibitor development platform.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
₩6.50B
PeLeMed has raised a total of ₩6.50B in funding over 2 rounds. Their latest funding was raised on Dec 1, 2020 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 1, 2020 Series A ₩6.50B 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
PeLeMed is funded by 2 investors. SGI Venture Capital and Spring Camp are the most recent investors.
Investor Name Lead Investor Funding Round
SGI Venture Capital — Series A
Spring Camp — Series A
Cointime
เนื้อหา
บริษัท